REASONS FOR DIFFICULTY OF THE PHARMACOECONOMIC ANALYSIS FOR ORPHAN DRUGS. WAYS FOR SOLUTIONS

• Auteurs principaux: Andrey Vladislavovich Pavlysh (Auteur), Aleksei Sergeevich Kolbin (Auteur), Roman Andreevich Gapeshin (Auteur), Stanislav Mikhailovich Malyshev (Auteur)
• Format: Livre
• Publié: IRBIS LLC, 2015-09-01T00:00:00Z.
• Sujets: article
• Accès en ligne: Connect to this object online.

Orphan drugs are used for treatment of rare life-threatening diseases. There is no universal definition of a rare disease and no universal approach to orphan drugs legislation. As a result, decision-making in this field requires results of pharmacoeconomic analysis, which structure and interpretatio...